FIELD: general improving health therapy. SUBSTANCE: mixture intended to correct dislipidemic conditions and hypercoagulation syndrome contains 42.8 to 93.0 wt % of eicosanepentaenic and docosahexaenic acids complex and complex of C12-C22- saturated and unsaturated fatty acids. EFFECT: enhanced efficiency and reduced time of treatment of conditions accompanied with elevated blood clotting; reduced appearance of adverse effects. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| FUNCTIONAL FOOD INGREDIENT WITH PRESET LIPID PROFILE | 2012 |
|
RU2524358C2 |
| HERBAL DRUG REGULATING POLYUNSATURATED FAT ACID CONTENT | 2010 |
|
RU2429872C1 |
| SPECIALIZED LIPID MODULE | 2014 |
|
RU2603583C2 |
| FUNCTIONAL FOOD PRODUCTS FOR PREVENTION OF CARDIOVASCULAR DISEASES | 2017 |
|
RU2651275C1 |
| BIOLOGICALLY ACTIVE DIETARY SUPPLEMENT FOR NORMALISING LIPID METABOLISM AND METHOD FOR APPLICATION THEREOF | 2020 |
|
RU2752298C1 |
| METHOD OF OBTAINING COMPOSITION WHICH CONTAINS UNSATURATED COMPOUNDS | 2004 |
|
RU2360952C2 |
| METHOD OF PRODUCING A BIOLOGICALLY ACTIVE ADDITIVE WITH POLY-SATURATED FATTY ACIDS | 2019 |
|
RU2716970C1 |
| ENRICHED OMEGA-3 FISH PARENTERAL NUTRITIOUS EMULSIONS OF OIL-IN-WATER TYPE | 2010 |
|
RU2555771C2 |
| ESSENTIAL FATTY ACIDS FOR PREVENTION AND/OR TREATMENT OF DEPRESSION IN PATIENTS SUFFERING FROM CORONARY HEART DISEASE OR CORONARY ARTERY DISEASE | 2005 |
|
RU2387448C2 |
| LIQUID ENTERAL NUTRIENT COMPOSITION SUITABLE FOR ENTERAL FEEDING, MINIMISING UPPER AND LOWER GASTROINTESTINAL COMPLICATIONS | 2010 |
|
RU2516782C2 |
